• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香料毒品不仅仅是无害的草药混合物:合成大麻素的药理学和毒理学综述。

Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

机构信息

Arkansas Department of Health, Public Health Laboratory, Little Rock, AR, United States.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):234-43. doi: 10.1016/j.pnpbp.2012.04.017. Epub 2012 Apr 26.

DOI:10.1016/j.pnpbp.2012.04.017
PMID:22561602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3936256/
Abstract

"K2" and "Spice" drugs (collectively hereafter referred to as Spice) represent a relatively new class of designer drugs that have recently emerged as popular alternatives to marijuana, otherwise characterized as "legal highs". These drugs are readily available on the Internet and sold in many head shops and convenience stores under the disguise of innocuous products like herbal blends, incense, or air fresheners. Although package labels indicate "not for human consumption", the number of intoxicated people presenting to emergency departments is dramatically increasing. The lack of validated and standardized human testing procedures and an endless supply of potential drugs of abuse are primary reasons why researchers find it difficult to fully characterize clinical consequences associated with Spice. While the exact chemical composition and toxicology of Spice remains to be determined, there is mounting evidence identifying several synthetic cannabinoids as causative agents responsible for psychoactive and adverse physical effects. This review provides updates of the legal status of common synthetic cannabinoids detected in Spice and analytical procedures used to test Spice products and human specimens collected under a variety of clinical circumstances. The pharmacological and toxicological consequences of synthetic cannabinoid abuse are also reviewed to provide a future perspective on potential short- and long-term implications.

摘要

“K2”和“香料”(统称香料)代表了一类相对较新的设计师药物,最近作为大麻的流行替代品出现,通常被称为“合法兴奋剂”。这些药物在互联网上很容易买到,并在许多专卖店和便利店以草药混合物、香薰或空气清新剂等无害产品的形式出售。尽管包装标签上注明“不可食用”,但因摄入这些药物而到急诊室就诊的人数却在急剧增加。缺乏经过验证和标准化的人体测试程序以及源源不断的潜在滥用药物,是研究人员难以充分描述与香料相关的临床后果的主要原因。虽然香料的确切化学成分和毒理学仍有待确定,但越来越多的证据表明,几种合成大麻素是导致精神活性和不良身体影响的原因。本文综述了在 Spice 中检测到的常见合成大麻素的法律地位的最新情况,以及用于检测 Spice 产品和在各种临床情况下收集的人体标本的分析程序。还综述了合成大麻素滥用的药理学和毒理学后果,以期对潜在的短期和长期影响提供未来展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab9/3936256/d4eb49dc925d/nihms550527f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab9/3936256/e249fb21fe93/nihms550527f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab9/3936256/d4eb49dc925d/nihms550527f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab9/3936256/e249fb21fe93/nihms550527f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab9/3936256/d4eb49dc925d/nihms550527f2.jpg

相似文献

1
Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.香料毒品不仅仅是无害的草药混合物:合成大麻素的药理学和毒理学综述。
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):234-43. doi: 10.1016/j.pnpbp.2012.04.017. Epub 2012 Apr 26.
2
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?与 Δ(9)-THC 相比,K2 合成大麻素具有独特的药理学和代谢:毒性更大的潜在机制?
Life Sci. 2014 Feb 27;97(1):45-54. doi: 10.1016/j.lfs.2013.09.017. Epub 2013 Sep 29.
3
[Spice drugs: cannabinoids as a new designer drugs].[香料药物:大麻素作为新型合成毒品]
Adicciones. 2009;21(3):181-6.
4
Spicing things up: synthetic cannabinoids.来点刺激的:合成大麻素。
Psychopharmacology (Berl). 2013 Aug;228(4):525-40. doi: 10.1007/s00213-013-3188-4. Epub 2013 Jul 9.
5
Beyond THC: The New Generation of Cannabinoid Designer Drugs.超越四氢大麻酚:新一代大麻素类设计药物。
Front Behav Neurosci. 2011 Sep 21;5:60. doi: 10.3389/fnbeh.2011.00060. eCollection 2011.
6
Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.四极杆飞行时间质谱法筛选草药混合物中的合成大麻素。
J Mass Spectrom. 2013 Jun;48(6):685-94. doi: 10.1002/jms.3217.
7
"Legal highs" - new players in the old drama.“新型毒品”——旧有毒品问题中的新角色。
Curr Drug Abuse Rev. 2011 Jun;4(2):122-30. doi: 10.2174/1874473711104020122.
8
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.英国对“香料”中合成大麻素受体激动剂的分类变化的影响。
Int J Drug Policy. 2011 Jul;22(4):274-7. doi: 10.1016/j.drugpo.2011.02.006. Epub 2011 Apr 8.
9
Synthetic cannabis.合成大麻。
Tidsskr Nor Laegeforen. 2012 Oct 30;132(20):2289. doi: 10.4045/tidsskr.12.0661.
10
Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.土耳其法医学委员会伊斯坦布尔麻醉品部门对草药化合物中合成大麻素的检测频率和类型进行的综述。
J Forensic Leg Med. 2013 Aug;20(6):667-72. doi: 10.1016/j.jflm.2013.03.041. Epub 2013 Apr 28.

引用本文的文献

1
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy.英国医用大麻注册:癫痫的临床结果分析
Brain Behav. 2025 Apr;15(4):e70490. doi: 10.1002/brb3.70490.
2
Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo-Pyridyl Synthetic Cannabinoid Receptor Agonist CH-FUBBMPDORA.新型氧代吡啶合成大麻素受体激动剂CH-FUBBMPDORA的内在受体激活潜力及代谢作用的鉴定与研究
Drug Test Anal. 2025 Sep;17(9):1623-1639. doi: 10.1002/dta.3854. Epub 2025 Feb 12.
3
Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models.

本文引用的文献

1
Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.管制物质清单:将三种合成大麻素临时列入第一类。最终命令。
Fed Regist. 2013 May 16;78(95):28735-9.
2
A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors.JWH-018 的主要葡萄糖醛酸化代谢物是 CB1 受体的中性拮抗剂。
Chem Res Toxicol. 2012 Apr 16;25(4):825-7. doi: 10.1021/tx3000472. Epub 2012 Mar 15.
3
Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.基质辅助激光解吸电离飞行时间质谱法直接筛选草药混合物中的新型合成大麻素。
通过体外和体内模型研究合成大麻素APP-CHMINACA(PX-3)的代谢谱。
Forensic Toxicol. 2025 Jan;43(1):130-141. doi: 10.1007/s11419-024-00705-0. Epub 2024 Nov 22.
4
Rapid screening and identification of novel psychoactive substances using PaperSpray interfaced to high resolution mass spectrometry.使用与高分辨率质谱联用的纸喷雾技术快速筛查和鉴定新型精神活性物质。
Clin Mass Spectrom. 2016 Sep 28;1:3-10. doi: 10.1016/j.clinms.2016.08.003. eCollection 2016 Nov.
5
Effect of EMB-FUBINACA on brain endothelial cell angiogenesis: Expression analysis of angiogenic markers.依替米星-富马酸福莫特罗对脑内皮细胞血管生成的影响:血管生成标志物的表达分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1613-1624. doi: 10.1007/s00210-024-03322-1. Epub 2024 Aug 13.
6
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials.基于活性的植物材料中合成大麻素受体激动剂的检测。
Harm Reduct J. 2024 Jul 1;21(1):127. doi: 10.1186/s12954-024-01044-4.
7
Exploring the topic structure and abuse trends of new psychoactive Substance since the 21st century from a bibliometric perspective.从文献计量学角度探讨21世纪以来新型精神活性物质的主题结构与滥用趋势。
Saudi Pharm J. 2024 Apr;32(4):101991. doi: 10.1016/j.jsps.2024.101991. Epub 2024 Feb 15.
8
Alternative Crops for the European Tobacco Industry: A Systematic Review.欧洲烟草行业的替代作物:一项系统综述。
Plants (Basel). 2024 Jan 15;13(2):236. doi: 10.3390/plants13020236.
9
Abuse of Synthetic Cannabinoids and Cathinones in a Patient on Buprenorphine-Naloxone Treatment: A Case Report.丁丙诺啡-纳洛酮治疗患者滥用合成大麻素和卡西酮:一例报告
Cureus. 2023 Nov 6;15(11):e48386. doi: 10.7759/cureus.48386. eCollection 2023 Nov.
10
Shifting drug markets in North America - a global crisis in the making?北美不断变化的毒品市场——一场正在形成的全球危机?
Int J Ment Health Syst. 2023 Oct 25;17(1):36. doi: 10.1186/s13033-023-00601-x.
J Mass Spectrom. 2012 Jan;47(1):141-6. doi: 10.1002/jms.2036.
4
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.K2 合成大麻素 JWH-073 的单羟基代谢物保留了中等至高的大麻素 1 型受体(CB1R)亲和力,并表现出中性拮抗剂到部分激动剂活性。
Biochem Pharmacol. 2012 Apr 1;83(7):952-61. doi: 10.1016/j.bcp.2012.01.004. Epub 2012 Jan 18.
5
Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight.中枢和外周大麻素受体作为控制食物摄入和体重的治疗靶点。
Handb Exp Pharmacol. 2012(209):357-81. doi: 10.1007/978-3-642-24716-3_17.
6
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase.大麻素与单胺神经递质及其对单胺氧化酶的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):68-77. doi: 10.1016/j.pnpbp.2011.12.010. Epub 2011 Dec 30.
7
Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use.大麻素受体的同源建模:用于治疗用途的大麻素类似物的发现。
Methods Mol Biol. 2012;819:595-613. doi: 10.1007/978-1-61779-465-0_35.
8
Convulsions associated with the use of a synthetic cannabinoid product.与使用合成大麻素产品相关的惊厥。
J Med Toxicol. 2012 Mar;8(1):62-4. doi: 10.1007/s13181-011-0182-2.
9
1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice.1-戊基-3-苯基乙酰吲哚类化合物和 JWH-018 在体内与大麻素在老鼠体内具有相似的特征。
Drug Alcohol Depend. 2012 Jun 1;123(1-3):148-53. doi: 10.1016/j.drugalcdep.2011.11.001. Epub 2011 Nov 27.
10
Designer drugs: a medicinal chemistry perspective.设计药物:从药物化学角度来看。
Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17.